NewsRoom Articles - Page 37 of 154 - PsychedelicNewsWire (PNW)

ThursdayMar 02, 2023 12:56 pm

Researchers Look Into Use of Psilocybin as Cluster Headaches Treatment

Researchers are looking to the nascent psychedelics market to find an alternative treatment for cluster headaches. A growing body of literature has already revealed that psychedelics can be effective at treating a myriad of mental health disorders when paired with psychotherapy. In fact, the majority of the research involving psychedelics, including psilocybin, MDMA and ketamine, has involved their potent mental health benefits. Yale University researchers have now published the results of the first-ever randomized double-blind, placebo-controlled study on the effects of psilocybin, the main psychoactive agent in magic mushrooms, on cluster headaches. These headaches are a rare neurological condition that…

WednesdayMar 01, 2023 1:00 pm

Research Finds That Psychedelics May Help Smokers Reinvent Themselves

Psychedelic therapies have become very popular these last few years after different studies found that these drugs could be useful in the treatment of a range of mental health conditions, including substance use disorder. A new study, carried out by scientists at the University of Cincinnati, has determined that psychedelics may be useful in helping people stop smoking. A previous study, carried out by scientists at Johns Hopkins University, also determined that participants who wanted to stop smoking and used psilocybin combined with cognitive behavioral therapy were more likely to succeed than individuals who tried other techniques to quit smoking.…

TuesdayFeb 28, 2023 1:17 pm

Psychedelic Medicine Firm Pioneers Ayahuasca Pill

Ayahuasca is one of the several psychedelics that have exhibited significant potential as treatment for mental health disorders. Research has revealed that psychedelics such as ayahuasca are capable of alleviating the symptoms of conditions, including treatment-resistant depression and post-traumatic stress disorder, with minimal side effects. However, most of this research is in its infancy, and patients who are interested in psychedelic treatments either have to take part in clinical trials or travel long distances to access institutions that offer psychedelic-assisted therapy. Ayahuasca, for instance, has a rich history in Central and South America and has been traditionally used by some…

MondayFeb 27, 2023 2:08 pm

Oregon Nonprofit Donates $50,000 in Scholarships for Training Psychedelics Guides

The Healing Advocacy Fund is a nonprofit organization that works to implement high-quality, safe and equitable psychedelic therapy. Research has found that psychedelics such as psilocybin have the potential to treat mental health conditions, including depression, post-traumatic stress disorder and end-of-life anxiety, among other conditions. The organization supports the implementation of the psilocybin therapy program in the state of Oregon through advocacy and education. Earlier this year, Oregon became the first state in the United States to launch a legal psilocybin medicinal use program. The next day, Oregon Psilocybin Services started accepting applications for five types of licenses: manufacturer, facilitator,…

FridayFeb 24, 2023 11:39 am

Combining VR, Psychedelics May Be Effective Therapy

Psychedelic-assisted therapy has emerged as a possible alternative to pharmaceutical psychiatric medications in recent years. A growing body of research has revealed that hallucinogenic drugs such as ketamine, MDMA and psilocybin have therapeutic potential against mental health disorders, including depression and PTSD. When paired with psychotherapy, psychedelics induce profound and long-term benefits relatively quickly and with minimal doses. As the psychedelics for mental health segment is still in its infancy, researchers are still working to develop psychedelic-assisted therapies that could be deployed to the mass market. Some researchers have begun experimenting with virtual reality (VR) to figure out how physicians…

ThursdayFeb 23, 2023 2:51 pm

European Union Urged to Play Active Role in Psychedelic Research

In just a few short years, psychedelics have presented themselves as a potential alternative to pharmaceutical mental health therapies. Research into hallucinogenic drugs has revealed that they are capable of alleviating the symptoms of mental disorders, such as treatment-resistant depression, anxiety and PTSD, when paired with psychotherapy. But while countries such as the United States and Australia have taken great strides towards increasing psychedelic research and incorporating psychedelics into existing mental health treatment frameworks, the European Union is still trailing behind. A cross-party group of legislators is now calling on the EU to step up its efforts and act fast…

WednesdayFeb 22, 2023 12:52 pm

Studies Explore the Use of Psychedelics in Delaying or Reversing Aging

Aging is the number one cause of suffering and death globally, as noted by Dr. Andrew Steele, who authored a book on longevity. Steele, who’s majored in physics, argues that people could live to 200 if we came up with pharmacological solutions to eliminate the cells that degrade tissue function. One study carried out by scientists at Harvard Medical School found that epigenetics could drive aging in an organism. The research, which used mice models, demonstrated that a breakdown in epigenetic data caused the animals to age. The researchers also observed that reinstating the integrity of the epigenome reversed these…

WednesdayFeb 22, 2023 12:16 pm

Marigold PR hosts International Women’s Day Event for Cannabis and Psychedelics Industry

Women working in Cannabis and Psychedelics celebrate International Women’s Day with virtual networking event Marigold Marketing & PR, committed to support advancing women in emerging industries has announced it is hosting MarigoldLIVE: International Women’s Day. A virtual event, MarigoldLIVE: International Women’s Day, is open to audiences worldwide and will take place 2:00-4:30 p.m. EST on Wednesday, March 8th, 2023. The event will offer attendees a unique experience, providing collaboration, networking, inspiration, and advice for women's success in the emerging cannabis and psychedelics industries worldwide. “We’re thrilled to be hosting our fourth annual International Women’s Day event. Through our events we’ve…

WednesdayFeb 22, 2023 9:45 am

Silo Pharma Inc. (NASDAQ: SILO) Granted US Patent For SPC-15 to Prevent and Treat Stress-Induced Disorders

SILO issued US Patent by USPTO titled “Pharmacological Prophylactics Against Stress-Induced Affective Disorders In Females” Claims allowed by patent protect use of SPC-15 for treating stress-induced affective disorders, including anxiety and PTSD Other therapeutics in company pipeline include SPU-16 to treat multiple sclerosis, SPU-21 to treat rheumatoid arthritis, SPC-14 to treat Alzheimer’s disease Therapeutics developed by SILO may qualify for FDA’s streamlined 505(b)(2) regulatory drug approval pathway Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, was recently issued US Patent 11,491,120 by the US Patent and Trademark Office (“USPTO”) (https://ibn.fm/rMLOR). The…

TuesdayFeb 21, 2023 12:00 pm

Why Mescaline Studies Are Few

Scores of studies on the therapeutic potential of psychedelic substances have been conducted these last 20 years, with promising results showing that drugs such as MDMA, LSD and psilocybin may be useful in the treatment of various mental health conditions. These positive findings have fueled the psychedelics decriminalization and legalization movement greatly, despite the fact that the substances are illegal at the federal level. While numerous studies have been done on classic psychedelics, not enough studies have featured mescaline. Mescaline is a naturally occurring psychedelic that induces hallucinogenic effects when consumed. Some pharmacological companies and researchers have been trying to…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000